BFC Planning’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
BFC Planning's VYGR Position: Q3 2026 in Review
BFC Planning held its Voyager Therapeutics (VYGR) position steady in Q3 2026 at 4,000 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.
BFC Planning first reported a position in VYGR in Q3 2025 and has held it in 5 quarters since. The position peaked at $18.7K in Q3 2025. 83 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.
- BFC Planning held 4,000 shares of Voyager Therapeutics worth $10.7K as of Q3 2026.
- BFC Planning left its Voyager Therapeutics share count unchanged in Q3 2026.
- Voyager Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2347 holding.
- BFC Planning first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Voyager Therapeutics position peaked at $18.7K in Q3 2025.
- 83 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.